Access cutting-edge major depressive disorder treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access major depressive disorder specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related major depressive disorder treatment provided free
This is a 52-week open-label extension (OLE) study that will evaluate the safety, tolerability, and effectiveness of NMRA-335140 in participants with major depressive disorder (MDD). Participants who completed a parent study investigating the efficacy and safety of NMRA-335140 as a treatment for MDD (ie, NMRA-335140-301, NMRA-335140-302, or NMRA-335140-303), and complete the 6 weeks double-blind treatment, provide informed consent, and meet eligibility criteria, may enter this extension study.
Sponsor: Neumora Therapeutics, Inc.
Check if you qualify for this major depressive disorder clinical trial in Phoenix, AZ
If you're searching for major depressive disorder treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced major depressive disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.